Elevation Oncology Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	14.38	19.74	10.22	29.75	28.04	Upgrade
Depreciation & Amortization	0.6	0.54	0.59	0.59	0.45	Upgrade
Provision & Write-off of Bad Debts	-	-	-	-	-10.46	Upgrade
Other Operating Activities	-7	-14.82	8.66	-15.51	-14.35	Upgrade
Change in Accounts Receivable	-7.41	-3.93	18.83	-20.32	9.49	Upgrade
Change in Inventory	-13.88	6.25	-27.76	-0.16	-26.6	Upgrade
Change in Other Net Operating Assets	-50.76	40.98	-28.61	8.03	-1.84	Upgrade
Operating Cash Flow	-64.05	48.76	-18.08	2.39	-15.27	Upgrade
Capital Expenditures	-0.62	-0.23	-0.01	-0.18	-0.52	Upgrade
Investment in Securities	45	-64.76	-52.84	-	5.1	Upgrade
Other Investing Activities	13.85	7	8.26	8.74	8.73	Upgrade
Investing Cash Flow	58.24	-57.99	-2.1	30.57	13.81	Upgrade
Other Financing Activities	-	-	-0.09	-0.06	-0.06	Upgrade
Financing Cash Flow	-	-	-0.09	-0.06	-0.06	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0	Upgrade
Net Cash Flow	-5.82	-9.23	-20.26	32.9	-1.53	Upgrade
Free Cash Flow	-64.67	48.53	-18.09	2.21	-15.79	Upgrade
Free Cash Flow Margin	-115.71%	42.34%	-64.89%	1.23%	-11.86%	Upgrade
Free Cash Flow Per Share	-1.23	0.92	-0.34	0.04	-0.30	Upgrade
Cash Interest Paid	-	-	0.09	0.06	0.06	Upgrade
Cash Income Tax Paid	0.07	12.15	-14.75	17.95	9.82	Upgrade
Levered Free Cash Flow	-65.21	34.54	42.93	30.98	-15.76	Upgrade
Unlevered Free Cash Flow	-65.21	34.54	42.96	30.99	-15.74	Upgrade
Change in Working Capital	-72.04	43.3	-37.55	-12.44	-18.94	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.